Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis W Lim

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Investigative Ophthalmology & Visual Science|July 14, 2016
Optical Coherence Tomography Angiography Evaluation of the Parafoveal Vasculature and Its Relationship With Ocular FactorsColin S Tan, Louis W Lim, Vernon S Chow, et al.
Ophthalmology. Retina|May 4, 2019
Relationship between Myopia Severity and Macular Retinal Thickness on Visual Performance under Different Lighting ConditionsColin S Tan, Kelvin Z Li, Mellisa Tan, et al.
BMJ Open Ophthalmology|August 1, 2025
Anti-VEGF treatment switch in real-world DME patients: ranibizumab versus aflibercept for bevacizumab DME non-responding patients (SWIRL study)Louis W Lim, Darren Choy, Wen Jun Song, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Investigative Ophthalmology & Visual Science|July 14, 2016
Optical Coherence Tomography Angiography Evaluation of the Parafoveal Vasculature and Its Relationship With Ocular FactorsColin S Tan, Louis W Lim, Vernon S Chow, et al.
Ophthalmology. Retina|May 4, 2019
Relationship between Myopia Severity and Macular Retinal Thickness on Visual Performance under Different Lighting ConditionsColin S Tan, Kelvin Z Li, Mellisa Tan, et al.
BMJ Open Ophthalmology|August 1, 2025
Anti-VEGF treatment switch in real-world DME patients: ranibizumab versus aflibercept for bevacizumab DME non-responding patients (SWIRL study)Louis W Lim, Darren Choy, Wen Jun Song, et al.
Pageof 7